77
Participants
Start Date
July 31, 2011
Primary Completion Date
July 31, 2012
Study Completion Date
RO5285119
single and multiple ascending oral doses
placebo
single and multiple oral doses
Rennes
Strasbourg
Hoffmann-La Roche
INDUSTRY